Vulvovaginal candidiasis in Mato Grosso, Brazil: pregnancy status, causative species and drugs tests

• Autor(a) principal: Dias,Luciana Basili
• Data de Publicação: 2011
• Outros Autores: Melhem,Márcia de Souza Carvalho, Szeszs,Maria Walderez, Meirelles Filho,José, Hahn,Rosane Christine
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Brazilian Journal of Microbiology
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822011000400009
• topic: Vulvovaginal candidiasis; antifungal susceptibility testing; antifungal agents; Candida albicans

Causative agent in majority of VVC is Candida albicans, but infection due to non-C. albicans is common. Use of empiric antifungal therapy in Brazil due to syndromic management of vulvovaginitis could act as risk factor for increase resistance among VVC causative agents. From Mato Grosso patients, 160 with culture-proved among 404 women who had clinical symptoms of VVC, were enrolled in this study. 70 non-pregnant women and 90 pregnant women were included. Candida albicans was the most prevalent, representing 72.9% in the non-pregnant group and 92.3% in the pregnant group. Differences in species distribution were noted between the two groups, being C. parapsilosis the second more prevalent species among non-pregnant women. Susceptibility testing revealed high susceptibility to fluconazole (except for C. krusei), itraconazole, ketoconazole, and amphotericin B regardless the species (C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, C. krusei) analyzed.